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Summary: An interlaboratory study for the radioimmunological determination of calcitonin was performed within
the European PTH Study Group (ESPG), tö improve compauability using external quality control. Twelve laboratories
determined calcitonin in 21 deep frozen samples using their respective calcitonin radioimmunoassay Systems. The
samples included Standard curves of human cäleitonin (sequence 1—32) in serurn äs well äs in assay buffer, several
dilutions of a serum fröm a patient with meduUäry thyröid cärcinoma, and additional sera containing calcitonin levels
of clmical importarice. For eväluatiori, the known concenträtions were related to the measured values of each labor-
atory, and of all laboratories together. Except for one, the laboratories recognized the different dilutions used,
although absolute values were scattered over a wide ränge. Satisfactory agreement was reached only when the data
were calculated äs the percentage of a given value. In future, a serum with a well defmed and constant calcitonin con-
centration should be used äs an international Standard in all determination of calcitonin by radioimmünoassay.
Ringversuch zur radioimmunologischen Calcitoninbestimmung im Serum
Zusammenfassung: In einem von der European PTH Study Group (EPSG) veranstalteten externen Ringversuch nach
dem sogenannten „Münchner Modell" wurde die Vergleichbarkeit der radioimmunologischen Calcitoninbestimmung
überprüft. 12 teilnehmende Laboratorien erhielten 21 tiefgefrorene Serumproben mit einer versteckten Standardkurve
für humanes Calcitonin (Sequenz l—32) aufgelöst sowohl in Serum als auch in Puffer, zusätzlich Serumproben von
Patienten mit medullärem Schilddrüsencarcinom in verschiedenen Verdünnungen. Mit Ausnahme eines Laboratoriums
konnten alle die Verdünnungsschritte in der vorgegebenen Reihenfolge messen, obwohl die Absolutwerte über einen
weiten Bereich streuten. Erst nach Umrechnung der Meßergebnisse auf einen gemeinsamen Bezugswert ergab sich
eine befriedigende Übereinstimmung.* Für die Zukunft könnte eine solche konstante und gut definierte Serumprobe
als internationaler Standard im Radioimmunoassay für humanes Calcitonin verwendet werden.
Introduction ' carcinoma (medullary thyroid carcinoma) and tumours
secreting calcitonin ectopically, in renal insufficiency,
Elevated calcitonin concentrations in serum have been Or during pregnancy and lactation (1,2). With the
reported in various clinical conditions such äs C^cell- majority of published radioimmunoassays pathologically
elevated values can be measured with accuracy, while
A) Supported by SFB 136 -. Krebsforschung - Project E 3 levels in the normal ränge remain poorly defined.
2) Parathyrin Moreover absolute values vary considerably (3,4,5).
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For a better comparison of various radioimmunoassay
Systems for calcitonin determination, we performed
an international collaborative study within the European
PTH Study Group. A similar collaborative study was run
previously with parathyrin (6).
The external quality control survey presented here was
based on the "Munich Model" (7-9). Twelve labora-
tories participated in the measurement of 21 samples
using their routine calcitonin-radioimmunoassays. We
collected the data obtained in these laboratories and
related the results to the different methods and reagents
used. Since we were able to evaluate results of a rela-
tively large number of samples, some of the sources
of error could be pinpointed.
Materials and Methods
Test sera
Twenty one samples, each äs two aliquots (in plastic tubes,
Eppendorf® reactioh Vials), were sent frozen in dry ice to each
participant. The samples, which were randomly numbered
(tab. 1), included a six point Standard curve of synthetic human
calcitonin (sequence 1-32) (Ciba Geigy) in serum äs well in
hormone-free buffer and a zero value. The Standard curve was
a geometric dilution of human calcitonin in concentrations
ranging from 0.3 to 9.6 Mg/1 dissolved in 0.05 mol/1 barbiturate
buffer pH 7.6 containing 50 ml/l of serum from a thyreoidecto-
mized patient and in pooled serum obtained from five normal
subjects with undetectable calcitonin levels. Calcitonin was
also undetectable in the serum of the thyreoidectomized
patient.
Furthermore five dilution Steps were included ranging from
l :4 to l :64 of a serum from patient B.F. with medullary
thyroid carcinoma diluted in the pooled normal serum, together
with another serum pool of medullary thyroid carcinoma
patients with high calcitonin levels.
Collaborating laboratories
The twelve collaborating laboratories are listed by code
numbers to preserve anonymity.
Radioimmunoassay technique
Technical details of the radioimmunoassays used are listed on
table 2. Eight different antisera against human calcitonin were
obtained by immunising goats in nine instances and chicken,
rabbit or guinea pig in the others. Some laboratories employed
different antisera for comparison. Synthetic human calcitonin
was radioiodinated with l!25I or 131I using the chloramine T
method according to Hunter & Greenwood (10); specific
activities ranged from 2.6-16.7 MBq/Mg. Some laboratories
purified the labelled hormone by gel filtration, others by
QUSO extraction (11). äs the Standard, ten Laboratories used
synthetic human calcitonin (sequence 1-32) from Ciba
Geigy, the other two using products from Armour and Organon,
respectively.
All the laboratories performed preincubations in the absence
of labelled hormone between eighteen hours and five days. Total
incubation times ranged from twenty five hours to eight days.
For Separation of the bound from the free hormone ten
laboratories used dextran coated charcoal, while two labora-
tories used polyethyieneglycol. All the laboratories mäde use
of homologous Systems with synthetic human calcitonin
(sequence l-32).
Results
Figures la—Ib show the results for determination of
the two Standard curves (samples 1-^-14 of tab. 1). In
each figure the added concentration is plotted on the
horizontal axis, the measured calcitonin concentrations
on the vertical äxis. The expected correlation between the
two sets of corresponding values is defined by a straight
line with a slope of 45°. All participating laboratories
except for one were able to measure increasing amounts
of human calcitonin in the given ränge of 0:3 to 9;6
jug/1- Calcitonin values measured in buffer (fig. Ife) or
serum (fig. la) did not differ. In cönträst, the absolute
values of the calcitonin concentrations differed con-
siderable, e.g. in the sample containing 0.3 jug/1,0.23
to l .55 $/1 were recovered. Moreover dilution cürves
of the serum from patient B.F. with medülläry thyroid
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Human colcitonin, given concentration I^tg/lj
9,6
Fig. l a. Relationships between given and measured concentra-
tions of human calcitonin; Standard dilutions in a
5 mol/1 barbkurate buffer containing a fraction of
serum of 0.05; x ± SD.
Ib. Relationship between given and measured concentra-
tions of geometric Standard dilutions with synthetic
human calcitonin düutedjn pooled normal serum with
undetectable calcitonin; ± SD.
le. Dilution Steps and measured values of the serum from
patient B.F. with medullary thyroid carcinoma diluted
in pooled normal serum with undetectable calcitonin;
' x±SD. .
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Except for one, all laboratories were able to detect the
different dilution Steps. From the five dilution Steps the
foüowing values were calculated for each laboratory:
mean concentration in undiluted serum, its Standard
error and the coefficient of Variation. From means
of each laboratory the same parameters were calculated
for all laboratories (tab. 3). The concentration of the
undiluted serum varied between 16.2 and 165.8 §/1,
the individual coefficient of Variation between l L5 to
69.3%. The mean value, considering all laboratories
except 4, 6 and 12, was 53.3 ± 25.1 ( ± SD) Mg/1 with
a coefficient of Variation for all laboratoiries (inter-
assay)öf46.9%.
In order to judge the clinical usefulness of human
absolute values the concentration in the serum of
patient B.F. with medullary thyroid carcinoma diluted
1:64 was referred to äs l and the values of the four
other dilutions were indicated äs a factor of this value.
The dilution curves expressed äs a factor of the first
dilution Step were closer together (fig. 2) than those
in absolute concentrations (fig. Ic).
In order to judge the clinical usefullness of human
calcitonin radioimmunoassay we evaluated the ability
to differentiate between normal and pathological values
using samples 15, 20 and 21 (tab. 1). In figure 3 the
reference ränge of all laboratories is indicated together
with the results of three sera. The pooled serum from
a patient with medullary thyroid carcinoma was expected
to show a very high calcitonin level. The serum from









1:64 1:32 1:16 1:8
Dilution
1:4
1:64 1:32 1:16 1:8 1:4
Dilution
Fig. 2. Dilution' curves äs in fig. Ic after recalculation using the
l :64 dilution Step äs 1.
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Tab. 1. Composition of the 21 test sera.
Matrix No. Syn? D ution


















B rbiturate buffer, 0:05 mol/1, 1 0
> pH 7.6 containing 50 ml/1 of 2 0.3
serum of a thyroidectomized 3 0.6
. J patient (d uent) 4 1.2
3 T 5 2.4
3 6 4.8a ra 7 9.6
^ Serum pooled from 5 normal 8 0
κρ volunteefs with undetectable 9 0.3
calcitonin concentrations 10 0.6
Ύ !. n 1.2
1 2 3 4 5 6 7 θ 9 10 11 12 1? 2.4
Loboratory code no. 13 4.8
14 9.6
Fig. 3 . Comparison of the reference ranges (hatched bars) and Serum from patient g. p yrfth χ$ ι .44
three measured values from the twelve laboratories medullary thyroid c rcinoma 16 1 :32
(undetectable calcitonin value = serum of the thyroid- ^^ in pooled> normal serum 17 1:16
ectomized patients; medium calcitonin value = serum lg j : g
dilution step 1:64 of the medullary thyroid carcinoma · . ±y j." 4
patient B.F.; high calcitonin = medullary thyroid
carcinoma serum pool). c ̂  o led ffon1 f ω atiehts 20
with medullary thyroid carcinoma




















goat, 3. 3. 77
goat, 3. 3. 77
goat, 3. 3. 77
goat, 3. 3. 77
8.11.75
goat, 18. 1. 78
goat, 6A, day 143
(Fischer)
goat, 8. 11. 75
goat, 6 A day 143
(Fischer)
goat, 3. 3. 77































































































x) hCT = human calcitonin
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l :64 should have had a concentration near the upper
limit of the reference raBge, and the serum of the
thyreoidectomized patient was practically calcitonin
free. In the 12 laboratories the upper limit of the normal
ränge varied between 0.05 and l .0 /zg/1, but was close
to 0.5 Mg/1 in most, The detection limit, which defmes
the lower limit of the reference ränge, was between
0.01 and 0.11 Mg/1, but predominately around 0.1 Mg/1.
Eight laboratories detected no calcitonin in the serum
of the thyroidectomized patient, while the values
measured in the other laboratories were within the
reference ränge. Nine laboratories recognized the serum
of the medullary thyroid carcinoma patient diluted
l :64 äs a pathological value slightly above the normal
ränge.
Conclusion
The participating laboratories in the comparative study
of the calcitonin determination were able to distinguish
between different concentrations of calcitonin, in
serum or buffer although the absolute values were
scattered over a wide ränge. Possible causes for these
differences include the known immunoheterogeneity
of circulating calcitonin (12), different reagents used
äs a Standard, tracer and antibodies and differerit times
and temperatures üsed for the incubation, and lastly
different Separation techniques. Although participants
used homologous radioimmunoassay Systems and only
one labpratory encountered technical problems with
the radioimmunoassay, the wide scatter of individual
values determined for one given concentration meant
that absolute values could not be used for comparison
of immunoassay results. A reaspnable agreement was
reached however, when the data were calculated äs a fac-
tor of a given value. We conclude that a Standard with a
defined calcitonin concentration should be used by all
laboratories äs an internal Standard in every assäy. This
Standard should be diluted in pooled serum äs well äs
Tab. 3. Means and coefficients of variations (CV) of the calci-
tonin concentrations measuied in the seium from patient
B.F. with medullary thyroid carcinoma (mean ( ) ± SD
of undiluted serum of the patient with medullary thyroid
carcinoma values äs calculated for each laboratory from






































































consensus value (mean of all laboratories excluding lab.







in buffer. We suggest that this Standard might be the
international reference preparation for calcitonin of
the National Institute for Biological Standards and
Control, which has been recently tested in a compara-
tive study of in vitro bioassays (13). Since this com-
parative study focussed on pathologically elevated
levells, the reference ränge was not defined. For clinical
purposes it is most important however to differeiitiate
between normal and slightly elevated calcitonin con-
centrations, for example in order to detect patients
with medullary thyroid carcinoma. Therefore sub-
sequent comparative studies are necessary to defme
the reference ränge.
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